|
⚲
|
| Keyboard |
| aeris Capital Equity Investments LP
✚
|
|
|---|---|
| CIK # | 0001605431 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001605431] | |
| 3 | [0001605431] | |
| 4 | [0001605431] | |
| SC 13G | [0001605431] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Aeris Capital Equity Investments LP | Adamas Pharmaceuticals Inc | [2015-02-10] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| aeris Capital Equity Investments LP | |
| Adamas Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2015-03-13 | Sell | 350,000 | $17.23 | 6,030,500 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-12-03 | Sell | 105,225 | $14.51 | 1,526,815 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-12-02 | Sell | 6,400 | $14.51 | 92,864 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-12-01 | Sell | 12,815 | $14.51 | 185,946 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-28 | Sell | 800 | $14.93 | 11,944 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-26 | Sell | 12,500 | $14.77 | 184,625 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-25 | Sell | 5,600 | $14.85 | 83,160 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-24 | Sell | 4,400 | $14.86 | 65,384 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-21 | Sell | 8,760 | $14.82 | 129,823 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2014-11-20 | Sell | 3,500 | $14.69 | 51,415 |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 4,265 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Stock · derivative
|
2014-04-15 | Conversion | 979,742 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA-1 Convertible Preferred Stock · derivative
|
2014-04-15 | Conversion | 300 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 4,265 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 4,265 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 4,265 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 4,265 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 10,017 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 8,814 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Series AA Convertible Preferred Warrant · derivative
|
2014-04-15 | Option exercise | 3,980 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||